comprehensive -WSS

comprehensive

author：fashion 2025-09-02 08:20:26 - browse：671

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Clinical trials giant ICON acquires HumanFirst

knowledge

WSS

Doctors in states that ban abortion can still help patients

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Congress gives doctors Medicare pay bump

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

'Weather

Change Healthcare cyberattack outage could last weeks

leisure time

comprehensive

hotspot

Guidelines to prevent youth baseball injuries need more muscle

International team creates first chimeric human

Duchenne breakthrough therapy leaves behind pioneering families

Clinical trials giant ICON acquires HumanFirst

Walensky prepares to leave CDC — and Congress — behind

A Q&A with Aletha Maybank, AMA’s chief health equity officer

The high cost of giving birth even with insurance

Poland's lawmakers approve a divisive law on Russian influence

Moonlake's readout produced a cash windfall. Risks remain

Covid isolation guidance eased by the CDC

focus

Doctors in states that ban abortion can still help patients

Clinical trials giant ICON acquires HumanFirst

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

HCA says smaller share of spending going to labor

Biotech companies concerned about China biosecurity crackdown

'Weather

focus

knowledge

leisure time

explore